The identification of specific methylation patterns across different cancers

Area of Science:

• Genomics
• Epigenetics
• Cancer Biology

Background:

• Abnormal DNA methylation is crucial in tumorigenesis.
• DNA methylation patterns can guide cancer diagnosis and therapeutic targeting.
• High-throughput analysis enables comprehensive study of epigenetic diversity across cancers.

Purpose of the Study:

• To investigate cancer-specific DNA methylation patterns across seven cancer types.
• To identify differentially methylated genes and construct a DNA methylation correlation network (DMCN).
• To explore the potential of methylation biomarkers for cancer prognosis and understand inter-cancer relationships.

Main Methods:

• Integrated whole-genome methylation data from 798 samples across seven cancers.
• Applied hierarchical clustering to identify cancer-specific methylation patterns.
• Constructed a DNA methylation correlation network (DMCN) and a protein-protein interaction (PPI) network.

Main Results:

• Discovered cancer-specific methylation patterns and identified 331 differentially methylated genes, with 266 being cancer-unique.
• Hub genes in the DMCN were enriched for cancer-specific genes.
• Identified seven biomarkers for breast cancer and eight for colon cancer that distinguish survival risk groups.
• Validated biological functions of differentially methylated genes using a PPI network, highlighting MAP3K14, PTN, ACVR1, and HCK.

Conclusions:

• Identified cancer-specific genes provide valuable references for personalized cancer treatment.
• Differential DNA methylation helps explain biological relationships across different cancer types.
• The study highlights the significance of epigenetic alterations in cancer heterogeneity and therapeutic strategies.